Get started
Author

Felicitas Scholten

Observed name: F. Scholten
Observed institution: Klinikum Frankfurt Höchst
ORCID: 0009-0008-7197-4255
Observed ORCID: 0009-0008-7197-4255
OpenAlex ID: A5113011177
Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
2022 · Ralf-Dieter Hofheinz, Sandro Anchisi, et al. · Cancers · 8
PDF
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers
2025 · Siyer Roohani, Jolina Handtke, et al. · Journal of Cancer Research and Clinical Oncology · 7
PDF
Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study
2023 · Gudrun Piringer, Josef Thaler, et al. · Journal of Geriatric Oncology · 4
Quality of life in patients treated with aflibercept and FOLFIRI for metastatic colorectal cancer: interim analysis with focus on therapy lines of the non-interventional study QoLiTrap (AIO-LQ-0113)
2019 · R. Hofheinz, F. Scholten, et al. · Annals of Oncology · 3
Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres
2026 · Markus Albertsmeier, Anna Tiefes, et al. · European Journal of Surgical Oncology · 1
Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma
2026 · Clara Walter, Michael C. Burger, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
PD-3 Impact of RAS status, prior targeted therapy, age, and gender on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer: Real-world data from the QoLiTrap study
2021 · R. von Moos, J. Thaler, et al. · Annals of Oncology · 1
Impact of RAS status and prior targeted therapy on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in daily practice. Final results of the QoLiTrap prospective non-interventional study.
2021 · Ralf Dieter Hofheinz, Hendrik Kröning, et al. · Journal of Clinical Oncology · 1
Correction: The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers
2025 · Siyer Roohani, Jolina Handtke, et al. · Journal of Cancer Research and Clinical Oncology
PDF
493P Impact of age on the activity of aflibercept plus FOLFIRI in metastatic colorectal cancer (mCRC): Real world data from the QoLiTrap study
2021 · J. Thaler, H. Kröning, et al. · Annals of Oncology
PDF
Quality of life (QoL) in patients with aflibercept (AFL) and FOLFIRI for metastatic colorectal cancer (mCRC): Interim analysis with focus on mutational status of the non-interventional study QoLiTrap (AIO-LQ-0113)
2019 · R. von Moos, F. Scholten, et al. · Annals of Oncology
Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap
2018 · M. Zahn, F. Scholten, et al. · Annals of Oncology
Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI – Interim results of the non-interventional AIO study QoLiTrap
2017 · R. von Moos, G. Derigs, et al. · Annals of Oncology
PDF
Works count: 13
Citation count: 26
H-index: 3
I10-index:
Year
Topic
Type